About Us
Our Services
All the activities of Erica Pharmed company serve to fill the existing gap between pharmaceutical companies and patients as well as physicians seeking access to newer and more efficient treatment options. Our extensive communication network affords pharmaceutical companies to implement their branding, marketing, and sales programs in an integrated, targeted, and patient- centered manner.

Pharmaceutical products marketing and sales

Importing of Pharmaceutical API & Finished products

Production of Hazard Medicines

Production of Human Supplement

Production of Pharmaceutical API
Departments
The aim of the young and tireless team of Erica Pharmed is to facilitate the access of patients to medications and innovative treatments with a continuous and creative fore-sighting effort, to create more effectiveness in the healthcare system of the country.
Our Vision
Our Mission
Our Partners

Sobhan Oncology
Sobhan Oncology, is the first oncology pharmaceutical company in middle east, founded in 2001. As a pioneer and innovator in Iran's pharmaceutical industry, Sobhan Oncology’s production lines are equipped with the state-of-the-art machinery and technology to manufacture high quality and safe oncology medicines. By using best practice experiences of the world, Sobhan Oncology strives to provide high quality best-in-class products to support & expand reliable and affordable medicines for all.
Read More
Celltech Pharmed
Celltech Pharmed-Stem Cell company was established in February 2013. The main goal of Caltech Pharmed-Stem Cell company is to create the essential infrastructure in order to improve access to the highest quality in the field of cell therapy, reducing pain and ultimately providing a better quality of life for all patients around the world. In the coming years, we will do our best to expand the novel treatment of cell therapy into various sectors of medical society to satisfy the needs of patients better.
Read More
Biosun Pharmed
Biosun Pharmed Company is one of the Barekat pharmaceutical holdings which was established in October 2012. The company is involved with research, development, and production of biosimilar products, vaccines, monoclonal antibodies and peptide medications.
Read More